Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Is AnaptysBio, Inc. (ANAB) A Good Stock To Buy?

The 700+ hedge funds and money managers tracked by Insider Monkey have already compiled and submitted their 13F filings for the fourth quarter, which unveil their equity positions as of December 31. We went through these filings, fixed typos and other more significant errors and identified the changes in hedge fund positions. Our extensive review of these public filings is finally over, so this article is set to reveal the smart money sentiment towards AnaptysBio, Inc. (NASDAQ:ANAB).

AnaptysBio, Inc. (NASDAQ:ANAB) was in 20 hedge funds’ portfolios at the end of December. ANAB has seen a decrease in hedge fund sentiment of late. There were 22 hedge funds in our database with ANAB holdings at the end of the previous quarter. Our calculations also showed that ANAB isn’t among the 30 most popular stocks among hedge funds.

At the moment there are a lot of methods market participants put to use to size up publicly traded companies. A couple of the less known methods are hedge fund and insider trading moves. We have shown that, historically, those who follow the top picks of the best investment managers can beat their index-focused peers by a significant margin (see the details here).

Sander Gerber of Hudson Bay Capital

Let’s take a look at the key hedge fund action surrounding AnaptysBio, Inc. (NASDAQ:ANAB).

What does the smart money think about AnaptysBio, Inc. (NASDAQ:ANAB)?

Heading into the first quarter of 2019, a total of 20 of the hedge funds tracked by Insider Monkey were bullish on this stock, a change of -9% from one quarter earlier. Below, you can check out the change in hedge fund sentiment towards ANAB over the last 14 quarters. So, let’s review which hedge funds were among the top holders of the stock and which hedge funds were making big moves.

ANAB_apr2019

Among these funds, Frazier Healthcare Partners held the most valuable stake in AnaptysBio, Inc. (NASDAQ:ANAB), which was worth $147.8 million at the end of the fourth quarter. On the second spot was Adage Capital Management which amassed $146.4 million worth of shares. Moreover, Cormorant Asset Management, Viking Global, and Deerfield Management were also bullish on AnaptysBio, Inc. (NASDAQ:ANAB), allocating a large percentage of their portfolios to this stock.

Seeing as AnaptysBio, Inc. (NASDAQ:ANAB) has witnessed bearish sentiment from hedge fund managers, it’s safe to say that there was a specific group of money managers that decided to sell off their entire stakes in the third quarter. At the top of the heap, Paul Marshall and Ian Wace’s Marshall Wace LLP sold off the largest investment of the “upper crust” of funds monitored by Insider Monkey, totaling close to $10.9 million in stock, and Dmitry Balyasny’s Balyasny Asset Management was right behind this move, as the fund dumped about $8.9 million worth. These bearish behaviors are interesting, as aggregate hedge fund interest dropped by 2 funds in the third quarter.

Let’s now review hedge fund activity in other stocks – not necessarily in the same industry as AnaptysBio, Inc. (NASDAQ:ANAB) but similarly valued. These stocks are First Merchants Corporation (NASDAQ:FRME), Stitch Fix, Inc. (NASDAQ:SFIX), Artisan Partners Asset Management Inc (NYSE:APAM), and Appian Corporation (NASDAQ:APPN). All of these stocks’ market caps match ANAB’s market cap.

Ticker No of HFs with positions Total Value of HF Positions (x1000) Change in HF Position
FRME 13 122400 0
SFIX 20 132132 -1
APAM 16 118757 3
APPN 9 246766 1
Average 14.5 155014 0.75

View table here if you experience formatting issues.

As you can see these stocks had an average of 14.5 hedge funds with bullish positions and the average amount invested in these stocks was $155 million. That figure was $623 million in ANAB’s case. Stitch Fix, Inc. (NASDAQ:SFIX) is the most popular stock in this table. On the other hand Appian Corporation (NASDAQ:APPN) is the least popular one with only 9 bullish hedge fund positions. AnaptysBio, Inc. (NASDAQ:ANAB) is not the most popular stock in this group but hedge fund interest is still above average. This is a slightly positive signal but we’d rather spend our time researching stocks that hedge funds are piling on. Our calculations showed that top 15 most popular stocks) among hedge funds returned 24.2% through April 22nd and outperformed the S&P 500 ETF (SPY) by more than 7 percentage points. Unfortunately ANAB wasn’t nearly as popular as these 15 stock and hedge funds that were betting on ANAB were disappointed as the stock returned 13% and underperformed the market. If you are interested in investing in large cap stocks with huge upside potential, you should check out the top 15 most popular stocks) among hedge funds as 13 of these stocks already outperformed the market this year.

Disclosure: None. This article was originally published at Insider Monkey.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading...